Clinical Trials · NCT00831233
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 42
- Start date
- Apr 2009
- Locations
- 33 sites, 3 countries
- Primary endpoint
- Change From Baseline in Total International Prostate Symptom Score (IPSS) at Week 12